These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8421109

  • 1. Lack of intrathyroidal tumor necrosis factor alpha in Graves' disease.
    Paschke R, Kist A, Jänicke R, Eck T, Velu T, Usadel KH.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):97-102. PubMed ID: 8421109
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
    Kasuga Y, Matsubayashi S, Akasu F, Miller N, Jamieson C, Volpé R.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1296-301. PubMed ID: 1902846
    [Abstract] [Full Text] [Related]

  • 4. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R, Vogg M, Swillens S, Usadel KH.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
    Paschke R, Vogg M, Kristoferitsch R, Aktuna D, Wawschinek O, Eber O, Usadel KH.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intrathyroidal dendritic cells.
    Kabel PJ, Voorbij HA, De Haan M, van der Gaag RD, Drexhage HA.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):199-207. PubMed ID: 3335603
    [Abstract] [Full Text] [Related]

  • 9. [Costimulatory molecule CD40 expression in thyroid tissue of Graves' disease patients and its immune pathogenetic significance].
    Wang FM, Chen XM, Hao C, Tang HB, Shen Q, Xu XY, Xu XG, Qian H, Li Q, Yao P, Li JH, Chen L.
    Zhonghua Yi Xue Za Zhi; 2013 Mar 12; 93(10):764-7. PubMed ID: 23755815
    [Abstract] [Full Text] [Related]

  • 10. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug 12; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 11. Intrathyroidal T cell accumulation in Graves' disease: delineation of mechanisms based on in situ T cell receptor analysis.
    Nakashima M, Martin A, Davies TF.
    J Clin Endocrinol Metab; 1996 Sep 12; 81(9):3346-51. PubMed ID: 8784095
    [Abstract] [Full Text] [Related]

  • 12. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R.
    J Clin Endocrinol Metab; 1988 Feb 12; 66(2):367-75. PubMed ID: 3276724
    [Abstract] [Full Text] [Related]

  • 13. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
    Zheng RQ, Abney ER, Chu CQ, Field M, Maini RN, Lamb JR, Feldmann M.
    Immunology; 1992 Mar 12; 75(3):456-62. PubMed ID: 1572693
    [Abstract] [Full Text] [Related]

  • 14. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
    Ueki Y, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Shimomura C, Matsunaga M, Tezuka H, Ishikawa N, Ito K.
    J Clin Endocrinol Metab; 1987 Nov 12; 65(5):922-8. PubMed ID: 2959679
    [Abstract] [Full Text] [Related]

  • 15. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease.
    Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A.
    N Engl J Med; 1991 Jul 25; 325(4):238-44. PubMed ID: 1829139
    [Abstract] [Full Text] [Related]

  • 16. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B, Londei M, Greenall C, Pirich K, Kassal H, Waldhäusl W, Feldmann M.
    J Clin Invest; 1988 May 25; 81(5):1608-14. PubMed ID: 3130398
    [Abstract] [Full Text] [Related]

  • 17. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
    Piccinini LA, Goldsmith NK, Schachter BS, Davies TF.
    J Clin Endocrinol Metab; 1988 Jun 25; 66(6):1307-15. PubMed ID: 2453529
    [Abstract] [Full Text] [Related]

  • 18. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
    Fisfalen ME, DeGroot LJ, Quintans J, Franklin WA, Soltani K.
    J Clin Endocrinol Metab; 1988 Apr 25; 66(4):776-84. PubMed ID: 3257970
    [Abstract] [Full Text] [Related]

  • 19. Accumulation of identical T cell clones in the right and left lobes of the thyroid gland in patients with Graves' disease: analysis of T cell clonotype in vivo.
    Sekine T, Kato R, Kato T, Masuko-Hongo K, Kameko F, Maruyama M, Nishioka K, Yamamoto K.
    Endocr J; 2000 Apr 25; 47(2):127-36. PubMed ID: 10943736
    [Abstract] [Full Text] [Related]

  • 20. IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease. Analysis of V alpha transcript microheterogeneity.
    McIntosh RS, Tandon N, Pickerill AP, Davies R, Barnett D, Weetman AP.
    J Immunol; 1993 Oct 01; 151(7):3884-93. PubMed ID: 8376808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.